NUCRYST Pharmaceuticals Corp. (NCS-T) Stock Predictions - Stockchase
WATCH LIST
4
NUCRYST Pharmaceuticals Corp. (NCS-T)

ON STOCKCHASE SINCE Aug 2006

biotechnology/pharmaceutical

NUCRYST Pharmaceuticals C...

NCS-T

0 watching          
Join the Discussion

NUCRYST Pharmaceuticals Corp. (NCS-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about NCS-T



  • All
  • Filtered
Signal Opinion Expert
DON'T BUY
Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Their acne treatment was not approved previously by the FDA, but suddenly was in July.. The approval isn’t doing a great deal for it.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$2.990
Owned Owned
No

PAST TOP PICK
(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Aug 24/06. Down 79.5%.) Their cream for treating acne did not get approved by the FDA, but did get approval 2 weeks ago. It might still be interesting. Sold his holdings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$2.960
Owned Owned
No

PAST TOP PICK
(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Aug 24/06. Down 52%.) Something went wrong with silver ointment treatment. They are back with silver bandaging. Based on the bandaging, it will be trading at 8-9 X earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$6.900
Owned Owned
Yes

TOP PICK
The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
The Silcryst bandaging spin off from Westaim (WED-T). (They still hold about 75%). Have developed/patented a technology for reducing nanotechnology silver to its crystalline level for application in ointments. Getting great revenues. Highly speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Michael Smedley

Exec VP & , Morgan Meighan & Ass...

Price Price
$14.600
Owned Owned
Yes

Showing 1 to 4 of 4 entries
Successfully Saved Company
Successfully Saved Company